All PlansReimbursementHigh impact
Reimbursement Policy Updates
BCBS Texas·TX · Pathology, Cardiology, Endocrinology +7 more·Reimbursement
Effective date
Jun 8, 2026
We identified it
Jun 24, 2026
Summary
Blue Cross Blue Shield of Texas updated 23 laboratory and diagnostic reimbursement policies effective between June 8, 2026 and September 4, 2026. These policies cover payment rules and methodologies for various laboratory tests including flow cytometry, biomarker testing, hormone testing, and cancer screening procedures.
Action Required
By June 8, 2026: Review and implement updated reimbursement policy RP039 for outpatient facility services overlapping during inpatient stays. By September 4, 2026: Billing team must review all 22 updated laboratory reimbursement policies (RPLAB001-RPLAB071) to understand new payment rules and coding requirements for procedures including flow cytometry, PSA testing, biomarker testing, allergen testing, hepatitis testing, thyroid testing, cardiovascular risk assessment, tumor markers, and various other laboratory services. Update billing software and staff training materials accordingly to ensure compliance with new reimbursement methodologies.